from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3322c/-

LFCtreatmentdescriptionclass of inhibitor

0.313

Amikacinug/mL Amikacintranslation

-0.899

Cap5-10ug/mL Capreomycintranslation

0.182

Rox10-50 ug/mL Roxithromycintranslation

0.868

SM2-5 ug/mL Streptomycintranslation

1.351

Tet5-10 ug/mL Tetracyclinetranslation

1.653

Rif0.2-5ug/mL Rifampicintranscription

0.654

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.632

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.269

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.150

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.144

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.343

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.521

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.072

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.138

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.949

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.085

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.639

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.111

KCN5-20 ug/mL Potassium cyaniderespiration

-0.872

NaN30.2-2 mM Sodium aziderespiration

-0.775

Nigericin50 uM Nigericinrespiration

0.412

TRC10-150 ug/mL Triclosanrespiration

-0.572

TRZ10-25 ug/mL Thioridazinerespiration

-0.629

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.022

menadione6-10 ug/mL Menadionerespiration

0.130

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.019

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.231

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.181

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.276

NRP_1Non-replicating persistence stage 1dosRassociated

-0.205

Amp0.2mg/mL AmpicillincellWall

-0.038

Cephalexin20-100 ug/mL CephalexincellWall

0.648

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.313

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.709

EMB10-20 ug/mL EthambutolcellWall

0.261

Eta12-40 ug/mL EthionamidecellWall

0.158

INH0.2-0.4 ug/mL IsoniazidcellWall

0.344

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.218

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.788

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.399

BZA0.12 mg/mL BenzamidearomaticAmides

-0.263

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.023

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.231

H2O24 mM hydrogen peroxideDNAdamaging

-0.041

Levo10 ug/mL LevofloxacinDNAdamaging

0.207

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.544

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.078

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.102

UVUV-irradiationDNAdamaging

0.737

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.028

Antimycin12.5-50 ug/mL Antimycin A?

-0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.096

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.282

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.296

PA8240.2-2 ug/mL PA-824?

0.278

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.393

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.108

Verapamil50 uM Verapamil?

-0.323

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.122

methoxatin10-20 ug/mL Methoxatin?